Recent news on Timolol Maleate

ISTA reports 91% increase in first quarter revenue  -  Apr 26, 2007
OSN SuperSite (subscription),Revenue from sales of Istalol (timolol maleate 0.5%) increased 29% to total $2.2 million, while revenue from Vitrase (hyaluronidase) sales increased 25% to

ISTA posts net loss of $38.4 million for 2006  -  Mar 7, 2007
OSN SuperSite (subscription),Net sales increased more than 200% for Xibrom (bromfenac ophthalmic solution 0.09%) and Istalol (timolol maleate 0.5%), rising to $20.2 million and $8.3

Allergan Reports Fourth Quarter Operating Results  -  Jan 31, 2007
Genetic Engineering News (press release),On December 21, 2006, Allergan announced that the FDA issued an approvable letter for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic

Allergan Announces FDA Issues Approvable Letter for Combigan ...  -  Dec 22, 2006
PharmaLive.com (press release),Administration (FDA) issued an approvable letter for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% for the reduction

Allergan Announces FDA Issues Approvable Letter for Combigan ...  -  Dec 22, 2006
PharmaLive.com (press release),Administration (FDA) issued an approvable letter for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% for the reduction

Centron Experiences Unprecedented Growth: Its First Anniversary  Aug 24, 2006
Additionally, Centron was named medical communications agency of record for Combigan? (brimonidine tartrate/timolol maleate), a new product from Allergan. -PharmaLive.com

Allergan Reports Second Quarter Operating Results; Total Product ...  Aug 2, 2006
A fixed combination of bimatoprost 0.03% and timolol maleate 0.5%, GANFORT(R) offers powerful IOP-lowering efficacy comparable to the free combination of these ... -Business Wire

Yale Biomedical Engineers Receive Prestigious Early Career Awards  Jul 17, 2006
Erin Lavik was granted the award for her project "Sustained delivery of timolol maleate for management of elevated IOP for glaucoma," in collaboration with ... -Medical News Today

Allergan Gets FDA Nod For Eye Drop LUMIGAN As First-line Treatment ...  Jun 23, 2006
The company said that GANFORT offers powerful IOP-lowering efficacy compared to the free combination of bimatoprost and timolol maleate and greater efficacy ... -Trading Markets



Study Demonstrates Benefits of Combination Treatment for Glaucoma  May 11, 2006
...clinically significant additional reduction in intraocular pressure (IOP) when treated with Cosopt® (dorzolamide hydrochloride/timolol maleate) alone or when ... - DG News





Committee for Medicinal Products for Human Use Summary of Positive ...  Mar 24, 2006
The active substances of Ganfort are bimatoprost and timolol (as timolol maleate), an antiglaucoma agent (ATC code: SO1ED 51), which contains a combination of ... - PharmaLive.com



European Medicines Agency: Committee for Medicinal Products for ...  Feb 23, 2006
Duotrav (travoprost/timolol maleate), Alcon Laboratories. Duotrav is an eye-drops solution, intended for the decrease of intraocular ... - PharmaLive.com,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional